[Venous thromboprophylaxis postcaesarean: survey of practices in Lorraine].
Vial
F
F
Hein
F
F
Boileau
S
S
Vedel
M
M
Bouaziz
H
H
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002585:Cesarean Section; D004363:Drug Utilization / Q000706:statistics & numerical data; D005260:Female; D005602:France; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009043:Motor Activity; D009765:Obesity / Q000150:complications; D011183:Postoperative Complications / Q000517:prevention & control*; D019106:Postoperative Hemorrhage / Q000139:chemically induced; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data*; D011247:Pregnancy; D011644:Puerperal Disorders / Q000139:chemically induced / Q000517:prevention & control*; D012307:Risk Factors; D053828:Stockings, Compression / Q000706:statistics & numerical data*; D011795:Surveys and Questionnaires; D019851:Thrombophilia / Q000188:drug therapy; D020246:Venous Thrombosis / Q000517:prevention & control*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight